Europe Ophthalmology Therapeutics Industry value to touch $7.78 billion by 2021

According to the report Europe Ophthalmology Therapeutics Industry, published by Market Data Forecast, The Industry was worth $5.58 billion in 2016 and estimated to be growing at a CAGR of 6.9%, to reach $7.78 billion by 2021. The Industry is showing evident potential in the mentioned forecast period.

Ophthalmology deals with the treatment of eye defects and diseases. Age related macular degeneration is the major cause of visual loss in adults in industrialised countries, other conditions associated with vision loss include cataract, diabetic retinopathy, and glaucoma along with low vision.

Browse Market data tables and in-depth TOC of the Europe Ophthalmology Therapeutics Industry to 2021 @

There are around 25 million people with visual impairment in the Europe. It is estimated that more than 70 million people have eye diseases that are in the early stages which if left untreated may lead to severe impairment.

Europe Ophthalmology Therapeutics is driven by the increasing incidence of vision impairment. Advancements in technology in the field of medicine are also playing a key role in the growth of the Industry. Growing geriatric population across the continent along with an increase in disposable income of the people are some of the factors adding up to the Industry growth. However, Stringent regulatory framework and unclear reimbursement policies are also acting as hurdles for Industry growth. Lack of awareness about various diseases associated with ophthalmology is also a major restraint hindering the Industry growth.

Free sample of the report is available @

Europe Industry for Ophthalmology Therapeutics is broadly segmented into Indication and End User. On the basis of indication, the Industry is analysed as Glaucoma, Dry Eye Syndrome, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration, Macular Edema and Allergic Conjunctivitis. Glaucoma is the largest indication segment accounting for a share of approximately 31% followed by AMD with a share of XX%. Based on End User the Industry is segmented into Hospitals, Eye Clinics, Diagnostic Centres and Patients. Geographically, Europe Ophthalmology Therapeutics Industry is segmented into United Kingdom, Germany, France, Italy and Spain. Within Europe, Germany is the largest Industry for Ophthalmology Therapeutics

Some of the major companies covered in the report are Pfizer Inc., Allergan Inc., Alcon Inc., Merck & co. Inc., Roche Valeant, Regeneron, Santen, Bayer, Senju, Lpath and Eye Gate Pharmaceuticals

Inquire before buying @

Key Points from Table of Contents


  • Executive Summary
  • Key Inferences
  • New Developments

Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

Europe Ophthalmology Therapeutics Industry: Segmentation

  • By Indication
    • Glaucoma
    • Dry Eye Syndrome
    • Diabetic Retinopathy
    • Retinal Vein Occlusion
    • Age-Related Macular Degeneration (AMD)
    • Macular Edema
    • Allergic Conjunctivitis
  • By End User
    • Hospitals
    • Eye Clinics
    • Diagnostic Centers
    • Patients

Geographical Analysis

  • UK
  • Spain
  • Germany
  • Italy
  • France

Strategic Analysis

  • PESTLE analysis
  • Porter’s Five analysis

Industry Leaders’ Analysis

Competitive Landscape

Avail discount @

About Us:

Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.


Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206

Visit MarketDataForecast Blog @

View latest Press Releases of MDF @

%d bloggers like this: